✦ LIBER ✦

993 - Exploiting hypoxia: Bioreductive drugs and gene therapy approache

✍ Scribed by Ian J. Stratford

Book ID: 117665235
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 222 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85752-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioreductive and gene therapy approaches

Bioreductive and gene therapy approaches to hypoxic diseases

✍ Mohammed Jaffar; Kaye J Williams; Ian J Stratford 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 929 KB

How to overcome (and exploit) tumor hypo

How to overcome (and exploit) tumor hypoxia for targeted gene therapy

✍ Olga Greco; Brian Marples; Michael C. Joiner; Simon D. Scott 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract Tumor hypoxia has long been recognized as a critical issue in oncology. Resistance of hypoxic areas has been shown to affect treatment outcome after radiation, chemotherapy, and surgery in a number of tumor sites. Two main strategies to overcome tumor hypoxia are to increase the deliver

Hypoxia response element-driven cytosine

Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro

✍ Laure Marignol; Ruth Foley; Thomas D. Southgate; Mary Coffey; Donal Hollywood; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract ## Background We proposed to exploit hypoxia‐inducible factor (HIF)‐1α overexpression in prostate tumours and use this transcriptional machinery to control the expression of the suicide gene cytosine deaminase (CD) through binding of HIF‐1α to arrangements of hypoxia response elements.